(GSBD) Goldman Sachs BDC - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US38147U1079
Stock: Debt Investments, Equity Investments, Middle Market, Private
Total Rating 22
Risk 52
Buy Signal -1.01
| Risk 5d forecast | |
|---|---|
| Volatility | 16.2% |
| Relative Tail Risk | 1.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.83 |
| Alpha | -27.18 |
| Character TTM | |
|---|---|
| Beta | 0.570 |
| Beta Downside | 0.954 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.59% |
| CAGR/Max DD | -0.08 |
EPS (Earnings per Share)
Revenue
Description: GSBD Goldman Sachs BDC March 04, 2026
Goldman Sachs BDC, Inc. (GSBD) operates as a business development company (BDC), focusing on debt and equity investments in private middle-market companies. BDCs are regulated investment vehicles that provide capital to developing firms, often those unable to access traditional bank financing.
GSBDs investment strategy emphasizes direct originations of secured and unsecured debt, including first lien, unitranche, and mezzanine debt, with a smaller allocation to equity. The fund targets investments between $10 million and $75 million in companies with annual EBITDA ranging from $5 million to $75 million. Mezzanine debt, for example, is a hybrid of debt and equity financing, typically used to finance the expansion of established companies.
For more detailed analysis of GSBDs portfolio and performance, consider exploring ValueRays comprehensive data.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 181.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -8.67 > 1.0 |
| NWC/Revenue: -2.18% < 20% (prev 8.22%; Δ -10.40% < -1%) |
| CFO/TA -0.03 > 3% & CFO -104.7m > Net Income 181.6m |
| Net Debt (-43.2m) to EBITDA (179.2m): -0.24 < 3 |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (115.6m) vs 12m ago 0.79% < -2% |
| Gross Margin: 77.35% > 18% (prev 0.41%; Δ 7694 % > 0.5%) |
| Asset Turnover: 10.46% > 50% (prev 5.34%; Δ 5.12% > 0%) |
| Interest Coverage Ratio: 0.00 > 6 (EBITDA TTM 179.2m / Interest Expense TTM 82.77b) |
Altman Z'' -0.34
| A: -0.00 (Total Current Assets 70.1m - Total Current Liabilities 78.1m) / Total Assets 3.38b |
| B: -0.13 (Retained Earnings -454.3m / Total Assets 3.38b) |
| C: 0.02 (EBIT TTM 61.3m / Avg Total Assets 3.49b) |
| D: 0.00 (Book Value of Equity 113.0k / Total Liabilities 1.96b) |
| Altman-Z'' Score: -0.34 = B |
Beneish M
| DSRI: 0.50 (Receivables 26.9m/28.1m, Revenue 365.6m/192.4m) |
| GMI: 0.53 (GM 77.35% / 40.90%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.90 (Revenue 365.6m / 192.4m) |
| TATA: 0.08 (NI 181.6m - CFO -104.7m) / TA 3.38b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of GSBD shares?
As of March 04, 2026, the stock is trading at USD 9.17 with a total of 1,425,060 shares traded.
Over the past week, the price has changed by +0.22%, over one month by -0.33%, over three months by -5.90% and over the past year by -14.62%.
Over the past week, the price has changed by +0.22%, over one month by -0.33%, over three months by -5.90% and over the past year by -14.62%.
Is GSBD a buy, sell or hold?
Goldman Sachs BDC has received a consensus analysts rating of 2.50.
Therefor, it is recommend to sell GSBD.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the GSBD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.1 | 9.7% |
| Analysts Target Price | 10.1 | 9.7% |
GSBD Fundamental Data Overview March 02, 2026
P/E Trailing = 7.8783
P/E Forward = 10.7759
P/S = 2.6972
P/B = 0.7106
P/EG = 2.15
Revenue TTM = 365.6m USD
EBIT TTM = 61.3m USD
EBITDA TTM = 179.2m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.84b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -43.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.83b USD (1.03b + Debt 1.84b - CCE 43.2m)
Interest Coverage Ratio = 0.00 (Ebit TTM 61.3m / Interest Expense TTM 82.77b)
EV/FCF = -27.09x (Enterprise Value 2.83b / FCF TTM -104.7m)
FCF Yield = -3.69% (FCF TTM -104.7m / Enterprise Value 2.83b)
FCF Margin = -28.63% (FCF TTM -104.7m / Revenue TTM 365.6m)
Net Margin = 49.67% (Net Income TTM 181.6m / Revenue TTM 365.6m)
Gross Margin = 77.35% ((Revenue TTM 365.6m - Cost of Revenue TTM 82.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 49.69%)
Tobins Q-Ratio = 0.84 (Enterprise Value 2.83b / Total Assets 3.38b)
Interest Expense / Debt = 4484 % (Interest Expense 82.69b / Debt 1.84b)
Taxrate = 0.89% (770.0k / 86.8m)
NOPAT = 60.7m (EBIT 61.3m * (1 - 0.89%))
Current Ratio = 0.90 (Total Current Assets 70.1m / Total Current Liabilities 78.1m)
Debt / Equity = 1.30 (Debt 1.84b / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = -0.24 (Net Debt -43.2m / EBITDA 179.2m)
Debt / FCF = 0.41 (negative FCF - burning cash) (Net Debt -43.2m / FCF TTM -104.7m)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.20% (Net Income 181.6m / Total Assets 3.38b)
RoE = 12.23% (Net Income TTM 181.6m / Total Stockholder Equity 1.48b)
RoCE = 1.85% (EBIT 61.3m / Capital Employed (Total Assets 3.38b - Current Liab 78.1m))
RoIC = 1.82% (NOPAT 60.7m / Invested Capital 3.34b)
WACC = 2.88% (E(1.03b)/V(2.88b) * Re(8.02%) + (debt cost/tax rate unavailable))
Discount Rate = 8.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.71%
[DCF] Fair Price = unknown (Cash Flow -104.7m)
EPS Correlation: -48.77 | EPS CAGR: -5.09% | SUE: 0.58 | # QB: 0
Revenue Correlation: 6.30 | Revenue CAGR: 31.51% | SUE: -0.00 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.32 | Chg7d=-0.008 | Chg30d=-0.008 | Revisions Net=-1 | Analysts=4
EPS current Year (2026-12-31): EPS=1.28 | Chg7d=-0.024 | Chg30d=-0.024 | Revisions Net=-1 | Growth EPS=-18.3% | Growth Revenue=-11.0%
EPS next Year (2027-12-31): EPS=1.21 | Chg7d=-0.040 | Chg30d=-0.040 | Revisions Net=-1 | Growth EPS=-5.7% | Growth Revenue=-3.9%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.7% (Discount Rate 8.0% - Earnings Yield 12.7%)
[Growth] Growth Spread = -5.3% (Analyst -9.9% - Implied -4.7%)
P/E Forward = 10.7759
P/S = 2.6972
P/B = 0.7106
P/EG = 2.15
Revenue TTM = 365.6m USD
EBIT TTM = 61.3m USD
EBITDA TTM = 179.2m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 1.84b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -43.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.83b USD (1.03b + Debt 1.84b - CCE 43.2m)
Interest Coverage Ratio = 0.00 (Ebit TTM 61.3m / Interest Expense TTM 82.77b)
EV/FCF = -27.09x (Enterprise Value 2.83b / FCF TTM -104.7m)
FCF Yield = -3.69% (FCF TTM -104.7m / Enterprise Value 2.83b)
FCF Margin = -28.63% (FCF TTM -104.7m / Revenue TTM 365.6m)
Net Margin = 49.67% (Net Income TTM 181.6m / Revenue TTM 365.6m)
Gross Margin = 77.35% ((Revenue TTM 365.6m - Cost of Revenue TTM 82.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 49.69%)
Tobins Q-Ratio = 0.84 (Enterprise Value 2.83b / Total Assets 3.38b)
Interest Expense / Debt = 4484 % (Interest Expense 82.69b / Debt 1.84b)
Taxrate = 0.89% (770.0k / 86.8m)
NOPAT = 60.7m (EBIT 61.3m * (1 - 0.89%))
Current Ratio = 0.90 (Total Current Assets 70.1m / Total Current Liabilities 78.1m)
Debt / Equity = 1.30 (Debt 1.84b / totalStockholderEquity, last quarter 1.42b)
Debt / EBITDA = -0.24 (Net Debt -43.2m / EBITDA 179.2m)
Debt / FCF = 0.41 (negative FCF - burning cash) (Net Debt -43.2m / FCF TTM -104.7m)
Total Stockholder Equity = 1.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.20% (Net Income 181.6m / Total Assets 3.38b)
RoE = 12.23% (Net Income TTM 181.6m / Total Stockholder Equity 1.48b)
RoCE = 1.85% (EBIT 61.3m / Capital Employed (Total Assets 3.38b - Current Liab 78.1m))
RoIC = 1.82% (NOPAT 60.7m / Invested Capital 3.34b)
WACC = 2.88% (E(1.03b)/V(2.88b) * Re(8.02%) + (debt cost/tax rate unavailable))
Discount Rate = 8.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.71%
[DCF] Fair Price = unknown (Cash Flow -104.7m)
EPS Correlation: -48.77 | EPS CAGR: -5.09% | SUE: 0.58 | # QB: 0
Revenue Correlation: 6.30 | Revenue CAGR: 31.51% | SUE: -0.00 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.32 | Chg7d=-0.008 | Chg30d=-0.008 | Revisions Net=-1 | Analysts=4
EPS current Year (2026-12-31): EPS=1.28 | Chg7d=-0.024 | Chg30d=-0.024 | Revisions Net=-1 | Growth EPS=-18.3% | Growth Revenue=-11.0%
EPS next Year (2027-12-31): EPS=1.21 | Chg7d=-0.040 | Chg30d=-0.040 | Revisions Net=-1 | Growth EPS=-5.7% | Growth Revenue=-3.9%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -4.7% (Discount Rate 8.0% - Earnings Yield 12.7%)
[Growth] Growth Spread = -5.3% (Analyst -9.9% - Implied -4.7%)